PRESTIGE-AF second annual meeting held in Graz, Austria on 6th December

Another year, another successful annual meeting. Hosted by PRESTIGE-AF partners, Medizinische Universitat Graz (MUG), the PRESTIGE-AF consortium convened in the idyllic and picturesque town of Graz in Austria on the 6th December for one full day of intense presentations, parallel session discussions and Scientific Advisory Board feedback.

The day started early at 8am, inviting the medical students of MUG to a seminar on the PRESTIGE-AF project. Dr Thomas Gattringer who is Additive Specialist Neurological Intensive Care at MUG, focussed his talk on the diagnosis and treatment of haemorrhagic stroke. With final remarks discussing the identified gaps in treatment guidelines, Dr Gattringer provided a smooth segue for Prof Roland Veltkamp to speak about the PRESTIGE-AF study. Coordinator of PRESTIGE-AF and Chair of Stroke Medicine at Imperial College London (UK), Prof Veltkamp explained to the students what PRESTIGE-AF, as an EU-funded, international collaborative research study, hopes to achieve in closing these gaps in stroke treatment guidelines and the expected research and patient impacts.

Prof. Roland Veltkamp explaining to medical students of MUG the importance of the PRESTIGE-AF Study. The PRESTIGE-AF Study aims to bolster treatment guidelines for patients with atrial fibrillation (AF) who have suffered an intracerebral haemorrhage (ICH)

After these talks, the PRESTIGE-AF consortium gathered and work group leaders provided updates on their research progress from the past year. A well-deserved lunch brought in the afternoon parallel sessions. With one group discussing predictive modelling and the other clinical trial coordination, partners used the time to ask each other questions and clarify the particulars around the PRESTIGE-AF clinical trials including protocols, responsibilities and technical requirements.

Dr Kathrin Foerster presenting the work package (WP) 13 update on behalf of PRESTIGE-AF partners, Heidelberg University Hospital (Germany).

The penultimate agenda item was the Scientific Advisory Board feedback presented to the Consortium. The Board commended the Consortium for all their efforts and progress over the year and this left good stead for Prof. Veltkamp to give his final remarks and closed the meeting on positive notes as we lead into the holiday season.

Overall, the meeting wonderfully prepared, organised and delivered by MUG was a huge success and plans are already underway for deciding which partner will host the next annual meeting.

Posted: 10th December 2019
See All Articles

This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 754517